Markel Co. (NYSE:MKL) has earned a consensus recommendation of “Buy” from the seven research firms that are covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating, two have given a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $1,265.25.
MKL has been the subject of a number of analyst reports. Zacks Investment Research raised Markel from a “hold” rating to a “strong-buy” rating and set a $1,361.00 price objective for the company in a research report on Monday, October 8th. ValuEngine lowered Markel from a “buy” rating to a “hold” rating in a research report on Monday, October 22nd. Finally, Boenning Scattergood set a $1,300.00 price objective on Markel and gave the company a “buy” rating in a research report on Wednesday, October 31st.
MKL stock traded down $99.61 on Friday, reaching $1,048.32. 8,049 shares of the company traded hands, compared to its average volume of 30,253. Markel has a one year low of $1,020.00 and a one year high of $1,228.32. The company has a quick ratio of 0.59, a current ratio of 0.59 and a debt-to-equity ratio of 0.31. The firm has a market cap of $15.78 billion, a PE ratio of 289.57 and a beta of 1.01.
Markel (NYSE:MKL) last posted its quarterly earnings data on Tuesday, October 30th. The insurance provider reported $28.50 earnings per share for the quarter, beating the Zacks’ consensus estimate of $7.05 by $21.45. Markel had a return on equity of 9.72% and a net margin of 14.03%. The company had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.77 billion. On average, research analysts expect that Markel will post 29.49 earnings per share for the current fiscal year.
In other Markel news, Vice Chairman Anthony F. Markel sold 149 shares of Markel stock in a transaction on Monday, November 5th. The stock was sold at an average price of $1,090.00, for a total value of $162,410.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Lemuel E. Lewis bought 250 shares of Markel stock in a transaction on Thursday, November 15th. The stock was acquired at an average cost of $1,096.50 per share, with a total value of $274,125.00. Following the acquisition, the director now owns 4,848 shares in the company, valued at approximately $5,315,832. The disclosure for this purchase can be found here. 2.53% of the stock is currently owned by company insiders.
Several institutional investors have recently bought and sold shares of MKL. Capital Guardian Trust Co. bought a new stake in shares of Markel in the 3rd quarter worth $108,000. Palo Capital Inc. bought a new stake in shares of Markel in the 3rd quarter worth $120,000. Signaturefd LLC increased its holdings in shares of Markel by 636.8% in the 2nd quarter. Signaturefd LLC now owns 140 shares of the insurance provider’s stock worth $152,000 after purchasing an additional 121 shares in the last quarter. Leavell Investment Management Inc. bought a new stake in shares of Markel in the 3rd quarter worth $208,000. Finally, Whitener Capital Management Inc. bought a new stake in shares of Markel in the 3rd quarter worth $216,000. 75.61% of the stock is owned by institutional investors and hedge funds.
Markel Company Profile
Markel Corporation, a diverse financial holding company, markets and underwrites specialty insurance products in the United States, the United Kingdom, Canada, and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment offers general and professional liability, property, personal line, program, and workers' compensation insurance products, as well as other insurance product lines, such as ocean marine, surety, CPI, and coverages.
Further Reading: What is a put option?
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.